Bonstein Sara
Chief Financial Officer at INSM; CFO/COO at ONCOSEC MEDICAL Inc; Chief Financial Officer at Advaxis, Inc.
- Sold, on record
- $44.4M
- Dollars the filings state
- Form 4 sales
- 29
- Latest Jun 3, 2026
- Form 144 notices
- 5
- Proposed sales
- Companies
- 3
- Filed as an executive or holder
Companies
- INSMINSMED IncChief Financial Officer
- ONCOSEC MEDICAL IncCFO/COO
- Advaxis, Inc.Chief Financial Officer
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- INSM610,213 shares
- Advaxis, Inc.42,377 shares
- ONCOSEC MEDICAL Inc2,462 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale INSMUnusualJun 10, 2025 2025
Sold 57,766 shares at $89.12 ($5.1M)
Bonstein Sara, Chief Financial Officer
10b5-1 planSold 35.8% of holdings ($14.4M position)103,412 shares left4.8x usual sizeFiling
- 2 Form 4 sale INSMUnusualJun 23, 2025 +13 days
Sold 57,765 shares at $101.78 ($5.9M)
Bonstein Sara, Chief Financial Officer
10b5-1 planSold 38.2% of holdings ($15.4M position)93,536 shares left4.4x usual sizeFiling
- 3 Form 4 sale INSMUnusualJul 7, 2025 +14 days
Sold 57,764 shares at $95.86 ($5.5M)
Bonstein Sara, Chief Financial Officer
10b5-1 planSold 40.7% of holdings ($13.6M position)84,017 shares left3.7x usual sizeFiling
- 4 Form 4 sale INSMUnusualJul 21, 2025 +14 days
Sold 58,400 shares at $102.67 ($6M)
Bonstein Sara, Chief Financial Officer
10b5-1 planSold 44.3% of holdings ($13.5M position)73,505 shares left3.2x usual sizeFiling
- 5 Form 4 sale INSMNo planJan 8, 2026 +171 days
Sold 4,642 shares at $174.22 ($809k)
Bonstein Sara, Chief Financial Officer
No 10b5-1 planSold 5.5% of holdings ($14.8M position)80,506 shares left0.3x usual sizeFiling
- 6 Form 4 sale INSMNo planFeb 3, 2026 +26 days
Sold 748 shares at $156.34 ($117k)
Bonstein Sara, Chief Financial Officer
No 10b5-1 planSold 0.9% of holdings ($12.6M position)79,758 shares left0x usual sizeFiling
- 7 Form 4 sale INSMNo planMay 13, 2026 +99 days
Sold 8,272 shares at $116.18 ($961k)
Bonstein Sara, Chief Financial Officer
No 10b5-1 planSold 10.4% of holdings ($9.3M position)71,486 shares left0.5x usual sizeFiling
- 8 Form 4 sale INSMNo planJun 3, 2026 +21 days
Sold 2,404 shares at $102.27 ($246k)
Bonstein Sara, Chief Financial Officer
No 10b5-1 planSold 3.4% of holdings ($7.3M position)69,082 shares left0.1x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (34)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jun 3, 2026 | Jun 5, 2026 | INSM | Chief Financial Officer | Form 4 sale | 2,404 | $246k | 3.4% | No plan | SEC |
| May 13, 2026 | May 15, 2026 | INSM | Chief Financial Officer | Form 4 sale | 8,272 | $961k | 10.4% | No plan | SEC |
| Feb 3, 2026 | Feb 4, 2026 | INSM | Chief Financial Officer | Form 4 sale | 748 | $117k | 0.9% | No plan | SEC |
| Jan 8, 2026 | Jan 8, 2026 | INSM | Chief Financial Officer | Form 4 sale | 4,642 | $809k | 5.5% | No plan | SEC |
| Jul 21, 2025 | Jul 23, 2025 | INSM | Chief Financial Officer | Form 4 sale | 58,400 | $6M | 44.3% | Unusual | SEC |
| Jul 7, 2025 | Jul 9, 2025 | INSM | Chief Financial Officer | Form 4 sale | 57,764 | $5.5M | 40.7% | Unusual | SEC |
| Jun 23, 2025 | Jun 25, 2025 | INSM | Chief Financial Officer | Form 4 sale | 57,765 | $5.9M | 38.2% | Unusual | SEC |
| Jun 10, 2025 | Jun 12, 2025 | INSM | Chief Financial Officer | Form 4 sale | 57,766 | $5.1M | 35.8% | Unusual | SEC |
| Jun 3, 2025 | Jun 4, 2025 | INSM | Chief Financial Officer | Form 4 sale | 1,579 | $113k | 1.4% | No plan | SEC |
| May 14, 2025 | May 15, 2025 | INSM | Chief Financial Officer | Form 4 sale | 10,504 | $709k | 8.8% | No plan | SEC |
| Feb 18, 2025 | Feb 20, 2025 | INSM | Chief Financial Officer | Form 4 sale | 18,322 | $1.5M | 13.4% | Routine | SEC |
| Feb 12, 2025 | Feb 13, 2025 | INSM | Chief Financial Officer | Form 4 sale | 18,321 | $1.5M | 11.8% | Routine | SEC |
| Feb 6, 2025 | Feb 7, 2025 | INSM | Chief Financial Officer | Form 4 sale | 28,390 | $2.3M | 15.4% | Unusual | SEC |
| Jan 10, 2025 | Jan 10, 2025 | INSM | Chief Financial Officer | Form 4 sale | 6,000 | $393k | 4.8% | No plan | SEC |
| May 29, 2024 | May 30, 2024 | INSM | Chief Financial Officer | Form 4 sale | 241,288 | $12.1M | 67.3% | Unusual | SEC |
| May 28, 2024 | May 28, 2024 | INSM | Officer | Form 144 notice | 241,288 | $12.1M | Notice | SEC | |
| May 14, 2024 | May 15, 2024 | INSM | Chief Financial Officer | Form 4 sale | 11,088 | $281k | 8.6% | No plan | SEC |
| May 14, 2024 | May 14, 2024 | INSM | Officer | Form 144 notice | 11,088 | $283k | Notice | SEC | |
| Jan 9, 2024 | Jan 11, 2024 | INSM | Chief Financial Officer | Form 4 sale | 4,497 | $131k | 3.8% | No plan | SEC |
| Jan 5, 2024 | Jan 5, 2024 | INSM | Officer | Form 144 notice | 9,294 | $271k | Notice | SEC | |
| Dec 22, 2023 | Dec 22, 2023 | INSM | Officer | Form 144 notice | 13,199 | $396k | Notice | SEC | |
| Dec 22, 2023 | Dec 22, 2023 | INSM | Chief Financial Officer | Form 4 sale | 13,199 | $396k | 11.1% | Unusual | SEC |
| May 16, 2023 | May 17, 2023 | INSM | Chief Financial Officer | Form 4 sale | 3,820 | $72k | 3.1% | No plan | SEC |
| May 15, 2023 | May 15, 2023 | INSM | Officer | Form 144 notice | 8,577 | $166k | Notice | SEC | |
| Jan 10, 2023 | Jan 12, 2023 | INSM | Chief Financial Officer | Form 4 sale | 2,857 | $52k | 4.1% | Plan not stated | SEC |
| May 16, 2022 | May 18, 2022 | INSM | Chief Financial Officer | Form 4 sale | 1,433 | $27k | 2.6% | Plan not stated | SEC |
| Jan 11, 2022 | Jan 13, 2022 | INSM | Chief Financial Officer | Form 4 sale | 1,154 | $29k | 3.1% | Plan not stated | SEC |
| Jan 16, 2020 | Jan 21, 2020 | ONCOSEC MEDICAL Inc | CFO/COO | Form 4 sale | 1,351 | $3k | 3.2% | Plan not stated | SEC |
| Oct 16, 2019 | Oct 18, 2019 | ONCOSEC MEDICAL Inc | CFO/COO | Form 4 sale | 1,111 | $2k | 2.5% | Plan not stated | SEC |
| Jan 3, 2018 | Jan 3, 2018 | Advaxis, Inc. | Chief Financial Officer | Form 4 sale | 5,224 | $17k | 2.3% | Plan not stated | SEC |
| Nov 6, 2017 | Nov 6, 2017 | Advaxis, Inc. | Chief Financial Officer | Form 4 sale | 3,862 | $13k | 1.7% | Plan not stated | SEC |
| Nov 2, 2017 | Nov 2, 2017 | Advaxis, Inc. | Chief Financial Officer | Form 4 sale | 12,734 | $41k | 5.2% | Plan not stated | SEC |
| Dec 30, 2016 | Jan 3, 2017 | Advaxis, Inc. | Chief Financial Officer | Form 4 sale | 5,520 | $41k | 4.2% | Plan not stated | SEC |
| Feb 24, 2016 | Feb 25, 2016 | Advaxis, Inc. | Chief Financial Officer | Form 4 sale | 15,037 | $84k | 15.8% | Plan not stated | SEC |